A Study to Examine the Potential Effect of Rifampin on the Pharmacokinetics of Bosutinib When Administered Concomitantly to Healthy Subjects.

Trial Profile

A Study to Examine the Potential Effect of Rifampin on the Pharmacokinetics of Bosutinib When Administered Concomitantly to Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 May 2009

At a glance

  • Drugs Bosutinib; Rifampicin
  • Indications Acute lymphoblastic leukaemia; Breast cancer; Chronic myeloid leukaemia; Tuberculosis
  • Focus Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 01 May 2009 Actual initiation date (Jul 2008) added as reported by ClinicalTrials.gov.
    • 01 May 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top